Ocular manifestations of systemic infections

Current Opinion in Ophthalmology

Volumn 10, Issue 6, 1999, Pages 452-457

  Uchio, Eiichi ^a   Ohno, Shigeaki ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; HYDROCORTISONE; INDOMETACIN; PROSTAGLANDIN E2; RAPAMYCIN; SPIRAMYCIN; TACROLIMUS;

ARTICLE; BACTERIAL INFECTION; CHORIORETINITIS; CLINICAL FEATURE; DISEASE ASSOCIATION; ENDOPHTHALMITIS; FUSARIUM SOLANI; FUSARIUM SOLANI INFECTION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; LISTERIA MONOCYTOGENES; LYME DISEASE; MYCOSIS; PRIORITY JOURNAL; RICKETTSIOSIS; SERRATIA MARCESCENS; TOXOCARIASIS; TOXOPLASMOSIS; UVEITIS; VIRUS INFECTION; VITRECTOMY;

ANIMALS; DIAGNOSIS, DIFFERENTIAL; EYE INFECTIONS; HUMANS;

EID: 0032720383     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-199912000-00014     Document Type: Article

References (46)

1. 1 Yamada R, Aida Y, Kakimoto S, Ueno S: Antibiotic-induced endotoxemia in a patient with endogenous endophthalmitis. Acta Ophthalmol Scand 1999, 77: 110-113.
2. 2 Chen SJ, Chung YM, Liu JH: Endogenous candida endophthalmitis after induced abortion. Am J Ophthalmol 1998, 125:873-875.
3. 3 Lohmann CP, Heep M, Linde HJ, Reischl U: Listeria monocytogenes-induced endogenous endophthalmitis in an otherwise healthy patient: PCR-assisted rapid diagnosis as the basis for successful therapy. Klin Monatsbl Augenheilkd 1998, 212:55-58.
4. 4 Marinella MA, Warwar R: Endogenous endophthalmitis due to Serratia marcescens. South Med J 1998, 91:388-391.
5. 5 Mendivil A, Cuartero V: Endogenous endophthalmitis caused by Rickettsia conorii. Acta Ophthalmol Scand 1998, 76:121-122.
6. 6 Sheu SJ, Chen YC, Kuo NW, Wang JH, Chen CJ: Endogenous cryptococcal endophthalmitis. Ophthalmology 1998, 105:377-381.
7. 7 Okhravi N, Dart JK, Towler HM, Lightman S: Paecilomyces lilacinus endophthalmitis with secondary keratitis: a case report and literature review. Arch Ophthalmol 1997, 115:1320-1324.
8. 8 Harrison SA, Bateman JB: Endogenous endophthalmitis caused by Streptococcus mitis. Am J Ophthalmol 1997, 123:260-261.
9. 9 Scherer WJ, Lee K: Implications of early systemic therapy on the incidence of endogenous fungal endophthalmitis. Ophthalmology 1997, 104:1593-1598.
10. 10 Mayayo E, Guarro J, Pujol I: Endogenous endophthalmitis by Fusarium solani: an animal experimental model. Med Mycol 1998, 36:249-253.
11. 11 Mikkila H, Seppala I, Leirisalo Repo M, Immonen I, Karma A: The etiology of uveitis: the role of infections with special reference to Lyme borreliosis. Acta Ophthalmol Scand 1997, 75:716-719.
12. 12 Pradella SP, Krause A, Muller A: Acute Borrelia infection. Unilateral papillitis as isolated clinical manifestation. Ophthalmologe 1997, 94:591-594.
13. 13 Koch F, Augustin AJ, Boker W: Neuroborreliosis with retinal pigment epithelium detachments. Ger J Ophthalmol 1996, 5:12-15.
14. 14 Schmidt BL: PCR in laboratory diagnosis of human Borrelia burgdorferi infections. Clin Microbiol Rev 1997, 10:185-201.
15. 15 Zaidman GW: The ocular manifestations of Lyme disease. Int Ophthalmol Clin 1997, 37:13-28.
16. 16 Meier P, Blatz R, Gau M, Spencker FB, Wiedemann P: Pars plana vifrectomy in Borrelia burgdorferi endophthalmitis. Klin Monatsbl Augenheilkd 1998, 213:351-354.
17. 17 Goto K, Sato K, Kurita M, Masuhara N, Iijima Y, Saeki K, Ohno S: The sero-prevalence of HTLV-I in patients with ocular diseases, pregnant women and healthy volunteers in the Kanto district, central Japan. Scand J Infect Dis 1997, 29:219-221.
18. 18 Yamamoto JH, Segurado AA, Hirata CE, Sampaio MW, Souza EC, Nukui Y, et al.: Human T-cell lymphotropic virus type 1 infection and ocular manifestations in Sao Paulo, Brazil. Arch Ophthalmol 1999, 117:513-517.
19. 19 Ohba N, Nakao K, Isashiki Y: HTLV-I associated retinochoroidal degeneration. Jpn J Ophthalmol 1996, 40:71-78.
20. 20 Nakamura H, Eguchi K, Nakamura T, Mizokami A, Shirabe S, Kawakami A, et al.: High prevalence of Sjogren's syndrome in patients with HTLV-I associated myelopathy. Ann Rheum Dis 1997, 56:167-172.
21. 21 Merle H, Smadja D, Le Hoang P, Bera O, Cabre P, Landau M, Vernant JC: Ocular manifestations in patients with HTLV-I associated infection-a clinical study of 93 cases. Jpn J Ophthalmol 1996, 40:260-270.
22. 22 Shibata K, Shimamoto Y, Nishimura T, Okinami S, Yamada H, Miyahara M: Ocular manifestations in adult T-cell leukemia/lymphoma. Ann Hematol 1997, 74:163-168.
23. 23 Sagawa K, Mochizuki M, Katagirl K, Tsuboi I, Sugita S, Mukaida N, Itoh K: In vitro effects of immunosuppressive agents on cytokine production by HTLV-I-infected T cell clones derived from the ocular fluid of patients with HTLV-I uveitis. Microbiol Immunol 1996, 40:373-379.
24. 24 Mochizuki M, Ono A, Ikeda E, Hikita N, Watanabe T, Yamaguchi K, et al.: HTLV-I uveitis. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 13(suppl 1):S50-S56.
25. 25 Jain SD, Uppal B, Mehta DK: Seroepidemiology of ocular toxoplasmosis-profile of an urban population. Indian J Pathol Microbiol 1998, 41:387-390.
26. 26 Guex Crosier Y, Auer C, Bernasconi O, Herbort CP: Toxoplasmic retinochoroiditis: resolution without treatment of the perilesional satellite dark dots seen by indocyanine green angiography. Graefes Arch Clin Exp Ophthalmol 1998, 236:476-478.
27. 27 Burnett AJ, Shortt SG, Isaac Renton J, King A, Werker D, Bowie WR: Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology 1998, 105:1032-1037.
28. 28 Ronday MJ, Ongkosuwito JV, Rothova A, Kijlstra A: Intraocular anti-Toxoplasma gondii IgA antibody production in patients with ocular toxoplasmosis. Am J Ophthalmol 1999, 127:294-300.
29. 29 Klaren VN, van Doornik CE, Ongkosuwito JV, Feron EJ, Kijlstra A: Differences between intraocular and serum antibody responses in patients with ocular toxoplasmosis. Am J Ophthalmol 1998, 126:698-706. Antibody specificity against T. gondii differed markedly in ocular fluid and in serum from patients with presumed chronic ocular toxoplasmosis. The intraocular T. gondii antibody response in patients with recurrent ocular toxoplasmosis differed from the systemic response.
30. 30 Ongkosuwito JV, Feron EJ, van Doornik CE, Van der Lelij A, Hoyng CB, La Heij EC, Kijlstra A: Analysis of immunoregulatory cytokines in ocular fluid samples from patients with uveitis. Invest Ophthalmol Vis Sci 1998, 39: 2659-2665.
31. 31 Hacker M, Richter R, Gumbel H, Richter T, Ohrloff C: Toxoplasmosis retinochoroiditis, a therapy comparison between spiramycin and pyrimethamine/ sulfadiazine. Klin Monatsbl Augenheilkd 1998, 212:84-87.
32. 32 Pearson PA, Piracha AR, Sen HA, Jaffe GJ: Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients. Ophthalmology 1999, 106:148-153. All patients who received atovaquone had a favorable response to treatment that began within 1 to 3 weeks. Visual acuity stabilized or improved in all patients.
33. 33 Gormley PD, Pavesio CE, Minnasian D, Lightman S: Effects of drug therapy on Toxoplasma cysts in an animal model of acute and chronic disease. Invest Ophthalmol Vis Sci 1998, 39:1171-1175.
34. 34 Garweg JG, Kuenzli H, Boehnke M: Experimental ocular toxoplasmosis in naive and primed rabbits. Ophthalmologica 1998, 212:136-141.
35. 35 Whittle RM, Wallace GR, Whiston RA, Dumonde DC, Stanford MR: Human antiretinal antibodies in toxoplasma retinochoroiditis. Br J Ophthalmol 1998, 82:1017-1021.
36. 36 Burney DP, Chavkin MJ, Dow SW, Potter TA, Lappin MR: Polymerase chain reaction for the detection of Toxoplasma gondii within aqueous humor of experimentally-inoculated cats. Vet Parasitol 1998, 79:181-186. In a cat model of ocular toxoplasmosis in which chorioretinitis developed, all cats developed T. gondii-specific IgG titers in serum and the aqueous humor. T. gondii was detected by PCR and southern blotting in the aqueous humors of both eyes in all cats.
37. 37 Hu MS, Schwartzman JD, Yeaman GR, Collins J, Seguin R, Khan IA, Kasper LH: Fas-FasL interaction involved in pathogenesis of ocular toxoplasmosis in mice. Infect Immunol 1999, 67:928-935.
38. 38 Magnaval JF, Michault A, Calon N, Charlet JP: Epidemiology of human toxocariasis in La Reunion. Trans R Soc Trop Med Hyg 1994, 88:531-533.
39. 39 Havasiova K, Dubinsky P, Stefancikova A: A seroepidemiological study of human toxocara infection in the Slovak republic. Helminthol 1993, 67:291-296.
40. 40 Holland CV, O'Lorcain P, Taylor MR, Kelly A: Sero-epidemiology of toxocariasis in school children. Parasitology 1995, 110:535-545.
41. 41 Sakai R, Kawashima H, Shibui H, Kamata K, Kambara C, Matsuoka H: Toxocara cati-induced ocular Toxocariasis. Arch Ophthalmol 1998, 116:1686-1687.
42. 42 Eberhard ML, Alfano E: Adult Toxocara cati infections in U.S. children: report of four cases. Am J Trop Med Hyg 1998, 59:404-406.
43. 43 Beiran I, Cochavi O, Miller B: "Silent" ocular toxocariasis. Eur J Ophthalmol 1998, 8:195-196.
44. 44 De Boer JH, Verhagen C, Bruinenberg M, Rothova A, De Jong PT, Baarsma GS, et al.: Serologic and polymerase chain reaction analysis of intraocular fluids in the diagnosis of infectious uveitis. Am J Ophthalmol 1996, 12:650-658.
45. 45 Wu Z, Nagano I, Xu D, Takahashi Y: Primers for polymerase chain reaction to detect genomic DNA of Toxocara canis and T. cati. J Helminthol 1997, 71: 77-78.
46. 46 Werner JC, Ross RD, Green WR, Watts JC: Pars plana vitrectomy and subretinal surgery for ocular toxocariasis. Arch Ophthalmol 1999, 117:532-534.